retatrutide 20 mg vial Retatrutide 20mg | Triple GIP/GLP-1/Glucagon

Beyond Nausea: Secondary and Emerging Side Effects While gastrointestinal effects dominate, GLP-1 injections may also produce fatigue, headache, appetite suppression beyond intended effects, and muscle loss in some patientsparticularly during rapid weight loss

JAMA 327(2):138150 Bergmann NC et al (2023) Semaglutide for the treatment of overweight and obesity: a review

Cardiovascular risk drops as triglycerides, LDL cholesterol and inflammatory markers come down

Several phase II trials and investigator-sponsored studies have explored the potential of GLP-1RAs in treating NAFLD and NASH (Table 2)

Gglucagon-like peptide-1 analogue liraglutide (Saxenda): mechanism of action, efficacy for the treatment of obesity